0001209191-18-050061.txt : 20180907
0001209191-18-050061.hdr.sgml : 20180907
20180907162100
ACCESSION NUMBER: 0001209191-18-050061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180906
FILED AS OF DATE: 20180907
DATE AS OF CHANGE: 20180907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WU JINN
CENTRAL INDEX KEY: 0001314254
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 181060390
MAIL ADDRESS:
STREET 1: 107 MORGAN LANE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-06
0
0001300699
Athenex, Inc.
ATNX
0001314254
WU JINN
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
1
0
0
0
Common Stock
2018-09-06
4
P
0
2500
16.088
A
266708
D
Stock Option (Right to Buy)
4.55
2021-05-09
Common Stock
16000
16000
D
Stock Option (Right to Buy)
4.55
2022-03-26
Common Stock
16000
16000
D
Stock Option (Right to Buy)
4.55
2013-01-02
2023-01-02
Common Stock
90000
90000
D
Stock Option (Right to Buy)
4.55
2014-02-12
2024-02-12
Common Stock
10000
10000
D
Stock Option (Right to Buy)
5.50
2015-02-05
2025-02-05
Common Stock
54000
54000
D
Stock Option (Right to Buy)
5.50
2025-03-20
Common Stock
96000
96000
D
Stock Option (Right to Buy)
11.00
2027-06-13
Common Stock
28500
28500
D
This transaction was executed in multiple trades at prices ranging from $16.084 to $16.089. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
The option vested in two equal annual installments beginning on May 9, 2012.
The option vested in full on March 26, 2013.
The option vested in full on March 20, 2017.
The option vests in four equal annual installments beginning on June 13, 2018.
/s/ Teresa Bair, Attorney-in-Fact
2018-09-07